This is consistent with the recent discovery that the methylation level of PM20D1 promoter cannot be directly translated into gene expression, due to blockage of an enhancer downstream for the hypermethylated groups (AD-risk associated haplotype). The gene discussed is PM20D1; the disease is Alzheimer disease.